This Week in Pediatric Oncology

cancer

Episodes

Thursday Jul 29, 2021

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/zZiE19fhzQQ
Tune in to the latest TWiPO episode as hosts, Dr. Timothy Cripe and Dr. Brenda Weigel, meet with Prof. Andy Pearson and Prof. Lou Chesler to discuss the ACCELERATE forums; Prof. Pearson & Prof. Chesler played pivotal roles in the start of the ALKi Pediatric Strategy Forum. Listen in as they discuss their experiences from the very first meeting, how topics are chosen, and the importance of bringing together key people from different industries. The ACCELERATE international platform provides a transparent forum to discuss and address, in a timely fashion, overarching issues in the development of innovative anticancer medicines for children and adolescents with cancer.
To learn more about ACCELERATE, please visit: https://www.accelerate-platform.org/

Monday Jun 28, 2021

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/PbNS-yFDTzA
Hosts Dr. Timothy Cripe & Dr. Brenda Weigel are joined by Dr. Samuel Blackman to discuss biotech solutions for pediatric cancer drug development. Dr. Blackman is the Co-Founder and Chief Medical Officer of Day One Biopharmaceuticals located in South San Francisco, CA. Tune in as Dr. Blackman discusses his career journey, the origins of Day One, and the challenges in pediatric cancer drug development today.
To learn more about Day One Biopharmaceuticals, go to https://dayonebio.com/.
Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org. Subscribe to TWIPO to get notifications of new uploads.
Want to listen to TWIPO's past episodes? Visit www.solvingkidscancer.org/podcast

Friday May 14, 2021

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/TEFcsd5lt1A
In recognition of Brain Tumor Awareness Month, TWIPO hosts Dr. Timothy Cripe and Dr. Brenda Weigel are joined by Dr. Stergios Zacharoulis of Columbia University Irving Medical Center (CUIMC), where he initiated a novel drug delivery program for pediatric brain tumors. Listen in as Dr. Zacharoulis discusses different delivery methodologies being explored and developed that bypass the blood brain barrier.
 
Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org. Subscribe to TWIPO to get notifications of new uploads. 

Friday Mar 12, 2021

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/R_GyqL36_dg
Hosts Dr. Tim Cripe and Dr. Brenda Weigel met with Dr. Gilles Vassal and Patricia Blanc on the ACCELERATE Platform: Innovation for Children and Adolescents with Cancer. Dr. Gilles Vassal is the head of Clinical Research at Institut Gustave Roussy in Villejuif, France & he is also the Chair for the ACCELERATE Steering Committee. Patricia Blanc is the President & Founder of the Imagine for Margo Foundation and serves as a Patient Advocate for ACCELERATE. Listen in to hear how the ACCELERATE platform came to be & the advances they are making within the childhood cancer research landscape. The ACCELERATE international platform provides a transparent forum to discuss and address, in a timely fashion, overarching issues in the development of innovative anticancer medicines for children and adolescents with cancer.
To learn more about ACCELERATE, please visit: https://www.accelerate-platform.org/
 

Friday Jan 29, 2021

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/io13HbVwtbI
Hosts Tim Cripe and Brenda Weigel welcome Dr. Chris Dandoy, from Cincinnati Children's Hospital, and parent advocate, Sarah Moore, to discuss the current research on TA-TMA and the implications for children undergoing stem cell transplant (SCT) for pediatric cancers, notably tandem SCTs for high-risk neuroblastoma.
 
Dr. Dandoy is Assistant Professor of Clinical Pediatrics in Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s Hospital Medical Center and this episode discussion focused on four recently published papers by Dr. Dandoy describing effects, incidence, risk factors, screening, and treatment of this serious complication of transplants. Sarah Moore also shared her perspective as a mother to a child who recently underwent tandem SCT for high-risk neuroblastoma, and has been active in parent forums discussing the incidence and implications of TA-TMA and sharing evidence-based information.
 
Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org.
 
Subscribe to TWIPO to get notifications of new uploads.
 
Want to listen to TWIPO's past episodes? Visit www.solvingkidscancer.org/podcast

Tuesday Dec 08, 2020

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/ANmLBfdVJYQ
Host Tim Cripe welcomes his new Co-Host, Dr. Brenda Weigel, to reflect on her career, leadership, and focus areas since her last interview on TWiPO in 2017. Dr. Weigel is the Director of the Division of Pediatric Hematology/Oncology at the University of Minnesota's Cancer Center, Chair of Developmental Therapeutics in the COG, and Chair of the Pediatric Early Phase Clinical Trials Network (PEP-CTN) for the NCI.
 
She is at the epi-center for getting new drugs into the clinic for children with cancer and shares her perspective on the impact of the game-changing RACE Act that was implemented in 2020. She weighs in on prioritization of same-class drugs, evolving clinical trial design for small patient populations, and the increasing need for international collaboration in conducting clinical trials. She also discusses the importance of quality-of-life assessments and patient-reported outcomes and shares the efforts ongoing in the US and EU regulatory landscape to advance drug development for children with cancer.

Wednesday Sep 30, 2020

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/p7rMXwAu3qA
This Week in Pediatric Oncology (TWIPO) - our host, Timothy Cripe, MD, meets with the new Chair of the Children's Oncology Group (COG), Douglas Hawkins, MD, to discuss the future of the pediatric cancer research landscape.
 
Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org. Subscribe to TWIPO to get notifications of new uploads.
 
You can now watch TWIPO podcasts on our YouTube Channel! Watch this episode here & subscribe: https://youtu.be/p7rMXwAu3qA

Tuesday Apr 28, 2020

• How is the pandemic changing current cancer care services?• What is the current state of open clinical trials and how will new, near-term trials be affected?• What is the impact on emerging new therapies and translational research?• Are there any silver linings to all of this for childhood cancer research?
These answers and more are discussed in this special episode for cancer families where leaders from COG, the NCI and the pharmaceutical industry lead a community discussion about the pandemic's impact on all aspects of pediatric cancer research including clinical trials and standard cancer care services, followed by Q&A with questions from families and attendees.
 
We are joined by:- Peter Adamson, MD – former Chair, Children's Oncology Group (COG) and current Global Head, Oncology Development & Pediatric Innovation, Sanofi
- Mark Kieran, MD, PhD – Pediatric Clinical Trial Lead, Bristol Myers Squibb
- Jeffery J. Auletta, MD - Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases Program at Nationwide Children's Hospital.
- Carol Thiele, Ph.D, Deputy Chief, National Cancer Institute (NCI) Pediatric Oncology Branch
- Prof. Pamela Kearns President, European Society of Pediatric Oncology (SIOPE), Director of Cancer Research UK Clinical Trials Unit
Moderated by: Timothy P. Cripe, MD, PhD – Chief of Hematology and Oncology at Nationwide Children’s Hospital
Hosted by: Solving Kids' Cancer US & UK, and Max Cure Foundation

Tuesday Mar 31, 2020

Experts from the medical community will update us on our progress to-date and what to expect in the coming weeks and months. Also, parents from a New York family both diagnosed with COVID-19 will share their family’s current story/experience and important insights from the frontline.Please join this timely webinar to hear expert opinions, real-life descriptions, ask questions, and share information on:• Progress on containing and treating the virus• Could viruses like COVID-19 be the new normal?• Medical services to pediatric cancer patients – how much of a delay right now?• Clinical research trials for cancer and other diseases on hold – impact to getting new treatments developed• Sharing a personal story: Real life with COVID-19 from a family’s perspective in New YorkQ&A to followGuest Speakers:• Timothy P. Cripe, MD, PhD, Chief of Hematology and Oncology, Nationwide Children’s Hospital• Jeffery J. Auletta, MD, Director of the Blood and Marrow Transplant (BMT) Program and Host Defense and Immunocompromised Infectious Diseases – Nationwide Children’s Hospital• New York couple diagnosed with COVID-19 at home with their family

Tuesday Mar 24, 2020

As our world faces the Novel Coronavirus pandemic, it’s vital that we address key topics important to children & families in the Pediatric Cancer CommunityPlease listen to this informative webinar to hear from experts, ask questions, and share information on:- An overview of COVID-19 pandemic: Fact versus fiction- COVID-19: What are the risks to immunocompromised patients?- Impact of COVID-19 on care and clinical researchExpert Discussion Leaders:Timothy P. Cripe, MD, PhD – Chief of Hematology and Oncology at Nationwide Children’s HospitalJeffery J. Auletta, MD - Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases Program at Nationwide Children's Hospital.
 
This audio was taken from a webinar, to watch the full video with resources click here: https://vimeo.com/400382067

Copyright 2014 . All rights reserved.

Podcast Powered By Podbean

Version: 20240320